Posted 12/14/2023, 10:50:04 PM
Gilead Sciences Stock Drops Despite Market Gains Ahead of Q4 Earnings
- Gilead Sciences (GILD) stock fell 1.58% despite gains in the broader market
- GILD is expected to report Q4 earnings of $1.78 per share, up 6.59% year-over-year
- GILD's revenue is projected to decline 4.26% to $7.07 billion in Q4
- For the full year, GILD earnings are seen down 7.16% and revenue to decrease 0.75%
- GILD currently trades at a forward P/E of 12.33, below its biotech industry average of 17.45